2 4 myositis, [3, 8] . Based on the cytoprotective properties of 17AAG in a range of myopathologies other 2 2 5 than myositis, we speculated that this agent might reduce ER stress-induced mitochondrial 2 2 6 dysfunction and limit potentially harmful ROS generation in skeletal muscle cells.
7
The in vitro model used here appears to mimic components of ER stress pathway activation in 2 2 8 myositic muscle, illustrated by observations of elevated protein levels of Grp78 and Grp94 in both in 2 2 9 vivo human and murine myositis [9] , and as illustrated by the increased XBP-1 gene splicing, 2 3 0 following Tunicamycin treatment of murine myotubes, [9, 26] . In the absence of ER stress-induced 2 3 1 apoptosis, the latter confirmed by the absence of caspase-12 cleavage, these current results suggest 2 3 2 that any bioenergetic changes induced in the presented murine model were not associated with muscle 2 3 3 cell death.
3 4
Myofibre atrophy is a key pathological feature of myositis. In the model being presented here, ER 2 3 5 stress induced significant myotubular atrophy; but this was preventable by the pharmacological 2 3 6 deployment of 17AAG. In view of the observation of induced myotubular atrophy, we investigated 2 3 7 key players thought likely to be involved in atrophy induction, i.e. the atrogenes Atrogin-1 and MuRF-2 3 8 1, and NF-κB activation. We have previously demonstrated the use of IkappaBalpha (IκBα) 2 3 9 degradation as a sensitive way of indirectly assessing nuclear factor kappa B (NF-κB) activity in 2 4 0 C2C12 myotubes, [27] . Surprisingly, in the current experiments, we observed no Tunicamycin-2 4 1 induced changes in Atrogin-1 or MuRF-1 gene expression levels. However, Tunicamycin-induced ER 2 4 2 stress did cause significant IκBα degradation, thus confirming that NF-κB activation had occurred, an 2 4 3 effect significantly reduced by 17AAG. A role for NF-κB activation in inducing myotubular atrophy 2 4 4 is well established in a rodent model of muscle wasting, [28] . Based on these observations we propose 2 4 5 that the in vitro murine model presented here mimics at least some features exhibited by muscle cells 2 4 6 from human myositis patients.
4 7
The current results confirm that ER stress pathway activation modifies myotubular oxygen utilisation, 2 4 8 as evidenced by declines in the RCR and P:O ratios and falls in total cellular ATP levels. 17AAG 2 4 9 prevented or ameliorated these induced bioenergetic deficits. Mechanistically these alterations in 2 5 0 mitochondrial function have previously been attributed to phosphorylation of JNK by the ER stress 2 5 1 receptor, inositol-requiring enzyme 1 (IRE1) α , with subsequent migration of the P-JNK complex to 2 5 2 the mitochondrial membrane, thus causing a depression of the ETC, [12, 29] . ER stress induced ETC 2 5 3 depression has also been associated with elevated mitochondrial ROS generation, with its potential to 2 5 4 cause oxidative damage to contractile proteins, [10] . In our in vitro model Tunicamycin-induced ER 2 5 5 stress pathway activation was associated with increased phosphorylation of JNK, an effect clearly 2 5 6 reduced by 17AAG. These findings support previous work linking ER stress activation to 2 5 7 mitochondrial dysfunction via JNK phosphorylation, [12] . The precise mechanism for the 2 5 8 downregulation of JNK phosphorylation is unclear. The activity of 17AAG orchestrated through its 2 5 9 inhibition of HSP90 suggests a wealth of client proteins which could mediate these changes [30] . 2 6 0 Some evidence has shown that heat shock protein 70 (a HSP90 client protein) can regulate JNK 2 6 1 phosphorylation, and this may be a mediator in our model -however, further investigation is needed 2 6 2 in this context [31, 32] .
6 3
Tunicamycin-induced ER stress pathway activation induced no changes in mitochondrial ETC 2 6 4 complex density or mitochondrial dynamics genes. These findings suggest that the observed 2 6 5 mitochondrial dysfunction was not due to changes in mitochondrial numbers or dynamics. In keeping 2 6 6 with the notion that ROS plays some role in mediating the downstream effects of ER stress activation, 2 6 7 we observed a decline in the total thiol (sulphydryl) pool and elevations in H 2 O 2 levels, in 2 6 8 combination with induced elevations of gene expression levels of SOD2 and PRDX3. ROS generation 2 6 9 in response to ER stress is well characterised, and its role in impairing mitochondrial function in 2 7 0 muscle may in part be associated with the activation of uncoupling proteins. In in vitro model 2 7 1 presented here, we observed elevated UCP-3 gene expression in response to ER stress. Uncoupling 2 7 2 proteins are redox sensitive, thus permitting proton leak across the inner mitochondrial membrane in 2 7 3 response to ROS generation, a process uncoupling the link between oxidative phosphorylation and 2 7 4 ATP synthesis, [33] . We therefore suggest that ER stress induces P-JNK/ROS-mediated uncoupling 2 7 5 of the ETC, causing decreased oxygen utilisation and ATP synthesis, effects clearly ameliorated by 2 7 6 17AAG. Our narrative of ROS involvement in these processes is supported by recent findings in a 2 7 7 murine model of myositis, whereby weakness is associated with interferon-γ-induced ROS generation, 2 7 8
Conclusions 2 8 0 ER stress is thought to play an important role in inducing non-immune cell-mediated muscle 2 8 1 contractile and energy deficits, and which are likely to apply in human myositis, [8, 9] . However, the 2 8 2 precise mechanisms mediating weakness-induction downstream of ER stress remain unexplained. In 2 8 3 the current experiments, we have modelled ER stress in vitro, and demonstrated obvious declines in 2 8 4 mitochondrial function, but which are mitigated by 17AAG. These observations suggest that chronic 2 8 5 ER stress in myositis may induce perturbations in mitochondrial function capable of causing 2 8 6 bioenergetic deficits, which likely contribute to muscle weakness-induction.
8 7
While recognising the limitations of the use of an in vitro model, the link between ER and 2 8 8 mitochondria is conserved across multiple species and cell types, so likely also applies in human 2 8 9 skeletal muscle cells. Given the crucial role that muscle ER plays in controlling the calcium fluxes 2 9 0 required to control complex muscle contractions, as well as controlling energy utilisation, it appears 2 9 1 likely that the mechanistic insights gained here do have some relevance for understanding human 2 9 2 myositis, and other ER stress-associated myopathologies. Tunicamycin induced significant fibre shrinkage, i.e. atrophy, an effect minimised by simultaneous 3 1 3 17AAG treatment; (B) Quantified densitometry and representative western blot images of IκBα - 
